118 HR 3813 IH: CDC Leadership Accountability Act of 2023 U.S. House of Representatives 2023-06-05 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I118th CONGRESS1st SessionH. R. 3813IN THE HOUSE OF REPRESENTATIVESJune 5, 2023Mr. Guthrie introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo accelerate the applicability of the requirement that the Director of the Centers for Disease Control and Prevention be appointed by the President, by and with the consent of the Senate.

1.

Short title

This Act may be cited as the CDC Leadership Accountability Act of 2023.

2.

Accelerating applicability of requirement that CDC Director be confirmed by Senate

Subsection (b) of section 2101 of division FF of the Consolidated Appropriations Act, 2023 (Public Law 117–328) is amended to read as follows: (b)

Applicability

(1)

In general

The first sentence of section 305(a) of the Public Health Service Act, as added by subsection (a), applies with respect to any Director of the Centers for Disease Control and Prevention appointed on or after June 1, 2023. (2)

Special rule

Any individual appointed during the period beginning on June 1, 2023, and ending on the date of enactment of this Act to serve as the Director of the Centers for Disease Control and Prevention is deemed to be serving in an acting capacity until the requirements of the first sentence of section 305(a) of the Public Health Service Act, as added by subsection (a), are met..